Literature DB >> 8404089

Progression of aortic stenosis. Role of age and concomitant coronary artery disease.

M Peter1, A Hoffmann, C Parker, T Lüscher, D Burckhardt.   

Abstract

To determine the spontaneous progression of valvular aortic stenosis and to delineate clinical factors related to progression, a longitudinal study, including 49 patients (aged 16 to 81 years), was performed. All patients had auscultatory findings of aortic stenosis and multiple Doppler echocardiograms separated by at least 11 months. Rapid progression of aortic stenosis was defined as an increase of maximal instantaneous pressure gradient by > or = 10 mm Hg per year. During a mean follow-up period of 32 months (11 to 66 months), maximal pressure gradient rose from 38 +/- 15 to 60 +/- 20 mm Hg in the entire study population, resulting in a median increase of 7.2 mm Hg per year. In 21 patients (43 percent), an increase of > or = 10 mm Hg per year was found; in this subgroup with rapid progression, patients were older (64 vs 53 years, p < 0.01) and coronary artery disease was more prevalent (38 percent vs 7 percent, p = 0.01). We conclude that nearly half the patients with initially mild to moderate valvular aortic stenosis reveal a progression of > or = 10 mm Hg per year.

Entities:  

Mesh:

Year:  1993        PMID: 8404089     DOI: 10.1378/chest.103.6.1715

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

Review 2.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

3.  Natural progression of low-gradient severe aortic stenosis with preserved ejection fraction.

Authors:  Antony Leslie Innasimuthu; Sanjay Kumar; Jason Lazar; William E Katz
Journal:  Tex Heart Inst J       Date:  2014-06-01

Review 4.  Changing strategy for aortic stenosis with coronary artery disease by transcatheter aortic valve implantation.

Authors:  Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-02

5.  A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis.

Authors:  P T Wilmshurst; R N Stevenson; H Griffiths; J R Lord
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

Review 6.  Insights into the use of biomarkers in calcific aortic valve disease.

Authors:  Erik Beckmann; Juan B Grau; Rachana Sainger; Paolo Poggio; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2010-07

Review 7.  Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review.

Authors:  Brian R Lindman; Devraj Sukul; Marc R Dweck; Mahesh V Madhavan; Benoit J Arsenault; Megan Coylewright; W David Merryman; David E Newby; John Lewis; Frank E Harrell; Michael J Mack; Martin B Leon; Catherine M Otto; Philippe Pibarot
Journal:  J Am Coll Cardiol       Date:  2021-12-07       Impact factor: 24.094

8.  Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors:  Cordelia J Barrick; Reade B Roberts; Mauricio Rojas; Nalini M Rajamannan; Carolyn B Suitt; Kevin D O'Brien; Susan S Smyth; David W Threadgill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

9.  Antithrombotic therapy in patients with prosthetic heart valves.

Authors:  Ha Mohamed
Journal:  Libyan J Med       Date:  2009-03-01       Impact factor: 1.657

10.  Calcific aortic valve damage as a risk factor for cardiovascular events.

Authors:  Jarosław Wasilewski; Kryspin Mirota; Krzysztof Wilczek; Jan Głowacki; Lech Poloński
Journal:  Pol J Radiol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.